+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-05-30Number of Pages: 128

Periodontal Therapeutics Market (Product - Systemic Antibiotics and Local Antibiotic; Distribution Channel - Hospitals Pharmacies, Retail Pharmacies, Drug Stores, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Periodontal Disease Therapeutics Market: Snapshot

Periodontal therapeutics are the non-surgical treatment for treatment of periodontal diseases.  Periodontal disease is a chronic in?ammatory disease characterized by in?amed gingiva, bleeding on probing, resorption of alveolar bone and attachment loss between the tooth and its surrounding alveolar bone. According to American Academy of Periodontology the prevalence of periodontal disease is highest among ethnic minorities, with 63.5 percent of Hispanic-Americans, 59.1 percent of Non-Hispanic Blacks and 50 percent of Non-Hispanic Asian Americans.

Untreated periodontal disease results in chronic inflammation that leads to increased insulin resistance, reduced glucose tolerance, and an increased risk of diabetic complications. According to company Colgate-Palmolive, the number of people in the world with diabetes will approximate 300 million by the year 2025 and a large number of diabetic people in the world will be in emerging economies such as India and China.

According to Transparency Market Research, the global periodontal disease therapeutics market will exhibit a CAGR of 8.7% from 2016 to 2024, rising to a valuation of US$537.2 mn by 2024.
periodontal therapeutics market

 

Local Antibiotics to Present More Promising Growth Opportunities

In terms of periodontal therapeutics products, the global periodontal therapeutics market has been segmented in the report into systemic antibiotics and local antibiotics. Of these, the segment of systemic antibiotics held a clear dominance, accounting for over 94% of the global market in 2016. The segment is expected to continue to remain at the top in terms of revenue contribution to the global market throughout the report’s forecast period, albeit with a slight decline as compared to its present share in the global market. Factors such as product affordability, availability, and high market penetration will continue to drive the demand for systemic antibiotics for the treatment of periodontal diseases.

The segment of local antibiotics is expected to lead in terms of growth rate over the forecast period, exhibiting a CAGR of 9.4% from 2016 to 2024. The vast advantages of local antibiotics such as fewer side effects, less chances of formation of resistant bacteria, direct local delivery, and 100 times greater concentration of antibiotics at the diseased site as compared to oral medication are likely to fuel the global demand for local antibiotics for the treatment of periodontal diseases.

North America to Continue Holding Dominant Share of Revenue of Global Market

In terms of geography, North America dominated the global periodontal therapeutics market, with a market share of over 40.0% in 2015.  The high market share of North America in the global periodontal therapeutics market is attributed to factors such as the growing prevalence of periodontal diseases, new product innovation, favorable reimbursement scenario, and the rapidly rising geriatric population. According to Center for disease control and prevention, 47.2% of adults aged 30 years and older have some form of periodontal disease. This, coupled with the high awareness among the population will present vast growth opportunities for the periodontal disease therapeutics market in North America over the forecast period.

The Asia Pacific market is expected to dominate in terms of growth rate over the report’s forecast period. Factors contributing to the growth of the market include the rapid population growth, increasing diabetes patient pool, favorable healthcare insurance policies, and growing awareness among people. Surging medical expenditures in emerging economies such as India and China , growing government initiatives, rapidly rising healthcare R&D investment, and the   presence of vast unmet medical needs will also drive the APAC periodontal therapeutics market over the forecast period. According to the National Commission on Macroeconomics and Health (NCMH), the prevalence of periodontal diseases in India was over 300 million in 2015. The prevalence is expected to rise in near future.

Some of the leading players operating in the global Periodontal Disease Therapeutics market are Valeant Pharmaceuticals international, Inc., 3M, Den-Mat Holdings, LLC Dexcel Pharma, and Galderma S.A.

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Periodontal Therapeutics: Market Snapshot
3.2 Market Share Analysis by Region, 2015
3.3 Global Periodontal Therapeutics Market: Opportunity Map

Section 4 Market Overview
4.1 Market Overview
4.2 Key Industry Developments

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
      5.2.1 Increase in incidence of periodontal disease across the world
      5.2.2 Influx of new drugs
      5.2.3 Rise in diabetic patient pool
      5.2.4 Increase in illegal drug abuse
      5.2.5 Growing awareness about oral health
      5.2.6 Patent expiry
5.3 Restraints
      5.3.1 Rise in consumer awareness and focus on prevention of dental and gum problems
      5.3.2 Uninsured dental care in several developed and developing countries
5.4 Opportunities
      5.4.1 Exploiting untapped markets for novel treatment options
      5.4.2 Drug pipeline
5.5 Periodontal Therapeutics Market Analysis and Forecast, 2016-2024
5.6 Porter’s Analysis
5.7 PEST Analysis
5.8 Product Pipeline Analysis
5.9 Reimbursement Scenario

Section 6 Periodontal Therapeutics Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 Global Periodontal Therapeutics Market Value Share Analysis, by Product Type
6.4 Periodontal Therapeutics Market Forecast, by Product Type 
6.5 Periodontal Therapeutics Market Analysis, by Product Type 
      6.5.1 Systemic Antibiotics
      6.5.2 Local Antibiotics
6.6 Periodontal Therapeutics Market Attractiveness Analysis By Product Type
6.7 Key Trends

Section 7 Periodontal Therapeutics Market Analysis, by Distribution Channel Type
7.1 Key Findings
7.2 Introduction
7.1 Key Findings
7.2 Introduction
7.3 Global Periodontal Therapeutics Market Value Share Analysis, by Distribution Channel
7.4 Periodontal Therapeutics Market Forecast, by Distribution Channel 
7.5 Periodontal Therapeutics Market Analysis, by Distribution Channel 
7.6 Periodontal Therapeutics Market Attractiveness Analysis by Product Type

Section 8  Periodontal Therapeutics Market Analysis, by Region
8.1 Global Periodontal Therapeutics Market Snapshot, by Country
8.2 Global Periodontal Therapeutics Market Value Share Analysis, by Region
8.3 Periodontal Therapeutics Market Forecast, by Region
8.4 Market Attractiveness Analysis, by Region

Section 9 North America Periodontal Therapeutics Market Analysis
9.1 Key Findings
9.2 Market Overview
9.3 Market Analysis, By Country
      9.3.1 North America Market Value Share Analysis, By Country
      9.3.2 North America Market Forecast By Country
9.4 North America Market Forecast By Product Type
      9.4.1 North America Market Value Share Analysis, By Product Type
      9.4.2 North America Market Forecast By Product Type
9.5 North America Market Forecast By Distribution Channel
      9.5.1 North America Market Value Share Analysis, By Distribution Channel
      9.5.2 North America Market Forecast By Distribution Channel
9.6 North America Market Attractiveness Analysis
      9.6.1 By Product
      9.6.2 By Distribution Channel

Section 10 Europe Periodontal Therapeutics Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Market Analysis, By Country
      10.3.1 Europe Market Value Share Analysis, By Country
      10.3.2 Europe Market Forecast By Country
10.4 Europe Market Forecast By Product Type
      10.4.1 Europe Market Value Share Analysis, By Product Type
      10.4.2 Europe Market Forecast By Product Type
10.5 Europe Market Forecast By Distribution Channel
      10.5.1 Europe Market Value Share Analysis, By Distribution Channel
      10.5.2 Europe Market Forecast By Distribution Channel
10.6 Europe Market Attractiveness Analysis
      10.6.1 By Product
      10.6.2 By Distribution Channel

Section 11 Asia Pacific Periodontal Therapeutics Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Market Analysis, By Country
      11.3.1 Asia Pacific Market Value Share Analysis, By Country
      11.3.2 Asia Pacific Market Forecast By Country
11.4 Asia Pacific Market Forecast By Product Type
      11.4.1 Asia Pacific Market Value Share Analysis, By Product Type
      11.4.2 Asia Pacific Market Forecast By Product Type
11.5 Asia Pacific Market Forecast By Distribution Channel
      11.5.1 Asia Pacific Market Value Share Analysis, By Distribution Channel
      11.5.2 Asia Pacific Market Forecast By Distribution Channel
11.6 Asia Pacific Market Attractiveness Analysis
      11.6.1 By Product
      11.6.2 By Distribution Channel

Section 12  Rest of the World Periodontal Therapeutics Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Market Analysis, By Country
      12.3.1 Rest of the World Market Value Share Analysis, By Country
      12.3.2 Rest of the World Market Forecast By Country
12.4 Rest of the World Market Forecast By Product Type
      12.4.1 Rest of the World Market Value Share Analysis, By Product Type
      12.4.2 Rest of the World Market Forecast By Product Type
12.5 Rest of the World Market Forecast By Distribution Channel
      12.5.1 Rest of the World Market Value Share Analysis, By Distribution Channel
      12.5.2 Rest of the World Market Forecast By Distribution Channel
12.6 Rest of the World Market Attractiveness Analysis
      12.6.1 By Product
      12.6.2 By Distribution Channel

Section 13 Company Profiles
13.1 Periodontal Therapeutics Market Share Analysis, by Company (2015)
13.2 Company Profiles
      13.2.1 3M
              13.2.1.1 Company Details
              13.2.1.2 Business Overview
              13.2.1.3 Financial Overview
              13.2.1.4 Strategic Overview
              13.2.1.5 SWOT Analysis
      13.2.2 Kaken Pharmaceutical Co., Ltd. 
              13.2.2.1 Company Details
              13.2.2.2 Business Overview
              13.2.2.3 Financial Overview
              13.2.2.4 Strategic Overview
              13.2.2.5 SWOT Analysis
      13.2.3 Valeant Pharmaceuticals International, Inc. 
              13.2.3.1 Company Details
              13.2.3.2 Business Overview
              13.2.3.3 Financial Overview
              13.2.3.4 Strategic Overview
              13.2.3.5 SWOT Analysis
      13.2.4 Den-Mat Holdings, LLC 
              13.2.4.1 Company Details
              13.2.4.2 Business Overview
              13.2.4.3 Financial Overview
              13.2.4.4 Strategic Overview
              13.2.4.5 SWOT Analysis
      13.2.5 Dexcel Pharma 
              13.2.5.1 Company Details
              13.2.5.2 Business Overview
              13.2.5.3 Financial Overview
              13.2.5.4 Strategic Overview
              13.2.5.5 SWOT Analysis
      13.2.6 Galderma S.A.
              13.2.6.1 Company Details
              13.2.6.2 Business Overview
              13.2.6.3 Financial Overview
              13.2.6.4 Strategic Overview
              13.2.6.5 SWOT Analysis

List of Figures

Figure 01: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 02: Global Systemic Antibiotics Market Revenue (US$ Mn) 2014–2024
Figure 03: Global Local Antibiotics Market Revenue (US$ Mn) 2014–2024
Figure 04: Periodontal Therapeutics Market Attractiveness Analysis, by Product Type, 2015
Figure 05: Global Doxycycline Market Revenue (US$ Mn) 2014–2024
Figure 06: Global Minocycline Catheters Market Revenue (US$ Mn) 2014–2024
Figure 07: Global Metronidazole Market Revenue (US$ Mn) 2014–2024
Figure 08: Global Others Market Revenue (US$ Mn) 2014–2024
Figure 09: Periodontal Therapeutics Market Attractiveness Analysis, by Systemic Antibiotics, 2015
Figure 10: Global Periodontal Therapeutics Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 11: Global Hospital Pharmacies Market Revenue (US$ Mn) 2014–2024
Figure 12: Global Retail Pharmacies Market Revenue (US$ Mn) 2014–2024
Figure 13: Global Drug Stores Market Revenue (US$ Mn) 2014–2024
Figure 14: Global E-Commerce Market Revenue (US$ Mn) 2014–2024
Figure 15: Periodontal Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 16: Global Periodontal Therapeutics Market Value Share Analysis, by Region, 2016 and 2024
Figure 17: Periodontal Therapeutics Market Attractiveness Analysis, by Region, 2015
Figure 18: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 19: North America Market Attractiveness Analysis, by Country, 2015
Figure 20: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure 21: North America Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 22: North America Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 23: North America Market Attractiveness Analysis, by Product Type, 2015
Figure 24: North America Market Attractiveness Analysis, by Distribution Channel Type, 2015
Figure 25: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 26: Europe Market Attractiveness Analysis, by Country, 2015
Figure 27: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 28: Europe Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 29: Europe Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 30: Europe Market Attractiveness Analysis, by Product Type, 2015
Figure 31: Europe Market Attractiveness Analysis, by Distribution Channel Type, 2015
Figure 32: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 33: Asia Pacific Market Attractiveness Analysis, by Country, 2015
Figure 34: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 35: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 36: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 37: Asia Pacific Market Attractiveness Analysis, by Product Type, 2015
Figure 38: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 39: Rest of the World Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 40: Asia Pacific Market Attractiveness Analysis, by Region, 2015
Figure 41: Rest of the World Market Value Share Analysis, by Country, 2016 and 2024
Figure 42: Rest of the World Market Value Share Analysis, by Product Type, 2016 and 2024

 

List of Tables

Table 01: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 02: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2014–2024
Table 03: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 06: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 07: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2014–2024
Table 08: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Branded Local Antibiotics, 2014–2024
Table 09: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 10: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 11: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 12: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2014–2024
Table 13: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 14: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2014–2024
Table 17: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 18: Rest of the World Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 19: Rest of the World Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 20: Rest of the World Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2014–2024
Table 21: Rest of the World Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024

Global Periodontal Therapeutics Market: Overview

Periodontal therapeutics are the non-surgical treatment procedure for treatment of periodontal disease. Based on the route of administration periodontal therapeutics are two types, such as local antibiotics and systemic antibiotics .The general purpose of local antibiotics is to reduce the number of bacteria present in the diseases periodontal pocket and the systemic antibiotics is to controlling bacterial infection. The report on global periodontal therapeutics market, analyzes the current and future prospects of the market. The report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by geography, in terms of revenue %, for 2015.

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the periodontal therapeutics market, along with porter’s analysis, and value chain analysis, of the global market, has been provided in this report. Market revenue analysis for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.

Global Periodontal Therapeutics Market: Scope of the Report

This report provides in-depth analysis of the periodontal therapeutics market. The stakeholders for this report include companies involved in the manufacturing of periodontal therapeutics. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the periodontal therapeutics market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.  

Global Periodontal Therapeutics Market: Segmentation

Based on product type, the global periodontal therapeutics market has been segmented into systemic antibiotics and local antibiotics. The systemic antibiotics segment is further categorized as doxycycline, minocycline, metronidazole and others. Others segment includes penicillin, amoxicillin etc. Local antibiotics are further segmented into Arestin and others. Based on end users, the market is segmented as hospitals pharmacies, retail pharmacies, drug stores and E-Commerce.

Based on geography, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, Spain, rest of Europe, China, Japan, India, Australia, and Rest of Asia Pacific. Rest of the world includes Latin America and Middle East & Africa. The report also comprises list major players in the market, their SWOT analysis, market share of these players in the periodontal therapeutics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Valeant Pharmaceuticals international, Inc., 3M, Den-Mat Holdings, LLC Dexcel Pharma, Galderma S.A. among others.

The global periodontal therapeutics market has been segmented as follows:

Global Periodontal Therapeutics  Market, by Product

  • Systemic Antibiotics
    • Doxycycline
    • Minocycline
    • Metronidazole
    • Others
  • Local Antibiotics
    • Arestin
    • Others

Global Periodontal Therapeutics  Market, by Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce

Global Periodontal Therapeutics  Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa


 
 
Back To Top